ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,669,635 | -36.2% | 69,530 | -35.7% | 0.03% | -37.8% |
| Q2 2023 | $7,318,300 | +12.9% | 108,083 | -9.8% | 0.04% | +12.5% |
| Q1 2023 | $6,480,477 | -10.7% | 119,787 | -1.3% | 0.04% | 0.0% |
| Q4 2022 | $7,259,200 | +0.7% | 121,371 | -23.8% | 0.04% | +11.1% |
| Q3 2022 | $7,206,000 | -20.8% | 159,314 | -1.9% | 0.04% | -7.7% |
| Q2 2022 | $9,102,000 | -12.6% | 162,387 | +10.8% | 0.04% | -7.1% |
| Q1 2022 | $10,419,000 | +48.7% | 146,519 | +36.4% | 0.04% | +2.4% |
| Q4 2021 | $7,008,000 | +4.3% | 107,390 | +19.9% | 0.04% | +10.8% |
| Q3 2021 | $6,720,000 | -16.5% | 89,557 | -13.2% | 0.04% | -28.8% |
| Q2 2021 | $8,048,000 | +3019.4% | 103,145 | +3171.3% | 0.05% | +2500.0% |
| Q1 2021 | $258,000 | – | 3,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Davide Leone & Partners Investment Co Ltd. | 87,705 | $6,237,000 | 92.18% |
| BARINGTON CAPITAL GROUP, L.P. | 160,941 | $11,445,000 | 13.78% |
| JANA PARTNERS LLC | 2,829,371 | $201,197,000 | 13.05% |
| Kent Lake Capital LLC | 110,000 | $7,822,000 | 4.86% |
| Nekton Capital Ltd. | 260,172 | $18,501,000 | 4.56% |
| REINHART PARTNERS, LLC. | 953,801 | $67,825,000 | 3.28% |
| CANYON CAPITAL ADVISORS LLC | 1,161,590 | $82,601,000 | 3.06% |
| Paradice Investment Management LLC | 666,404 | $47,388,000 | 2.77% |
| Concorde Financial Corp | 65,044 | $4,501,000 | 2.77% |
| Orchard Capital Management, LLC | 131,566 | $9,356,000 | 2.66% |